LHCG (NASDAQ:LHCG) Target Lowered by Truist Securities to $185.00

LHCG stock has undergone multiple analysts rating changes in the recent past.  stock Target Lowered by Truist Securities on 10/13/2021. In a note to investors, the firm issued a new target price of $185.00. The analysts previously had $240.00 target price. Truist Securities’s price target would indicate a potential upside of 32.85% from the stock’s previous close.

Shares of traded on Wednesday, reaching $142.63. 0 shares of the stock traded hands, compared to its average volume of 248483. On Wednesday, Shares of closed at $142.63. The firm’s 50 day moving average is $170.58 and its 200 day moving average is $194.00.  has a 12 month low of $133.74 and a 12 month high of $236.81. While on yearly highs and lows, today has traded high as $143.10 and has touched $137.00 on the downward trend.

Earnings and What to expect: 

LHC Group last released its quarterly earnings results on August 4th, 2021. The health services provider reported $1.62 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.55 by $0.07. The firm had revenue of $545.91 million for the quarter, compared to analyst estimates of $547.93 million. Its quarterly revenue was up 12.0% compared to the same quarter last year. LHC Group has generated $5.01 earnings per share over the last year ($3.73 diluted earnings per share) and currently has a price-to-earnings ratio of 38.2. Earnings for LHC Group are expected to grow by 7.75% in the coming year, from $6.45 to $6.95 per share. LHC Group has not formally confirmed its next earnings publication date, but the company’s estimated earnings date is Wednesday, November 3rd, 2021 based off prior year’s report dates.

Earnings for LHC Group are expected to grow by 7.75% in the coming year, from $6.45 to $6.95 per share. The P/E ratio of LHC Group is 38.24, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 14.75. The P/E ratio of LHC Group is 38.24, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 32.33. LHC Group has a PEG Ratio of 1.93. PEG Ratios above 1 indicate that a company could be overvalued. LHC Group has a P/B Ratio of 2.79. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

(NASDAQ:LHCG) Moving Average Technical Analysis

5 day Moving Average is $$140.96 And 5 day price change is -$2.60 (-1.79%)  with average volume for 5 day average is 347,540. While technical analysis for average 20 days shows significant difference, 20 day moving average is  $154.43 and 20 day price change is -$26.24 (-15.54%) and average 20 day moving volume is 277,580. 50 day moving average is $170.58  and 50 day price change is -$72.12 ( -33.58%)  and with average volume for 50 days is : 240,944. 200 day moving average is $194.00  and 200 day price change is -$74.26 (-34.24%)  and with average volume for 200 days is : 187,219.

Other owners latest trading in LHCG :

  • On 10/13/2021 shares held by Scout Investments Inc. were 71,052 which equates to market value of $11.15M and appx 0.20% owners of LHCG
  • On 10/13/2021 shares held by Private Capital Group LLC were 696 which equates to market value of $0.11M and appx 0.00% owners of LHCG
  • On 10/12/2021 shares held by Louisiana State Employees Retirement System were 8,100 which equates to market value of $1.27M and appx 0.00% owners of LHCG
  • In total Institutional ownership equates to Institutional Ownership Percentage: 92.14% for LHCG

See More Analyst Rating at: RATING